BPC 157: The Real Reason Why It's Not FDA Approved Stracuzzi Wellness Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Ars Technica US FDA to convene expert panel to review wider access to some peptides Reuters When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York